SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival

scientific article published on 22 July 2015

SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.18632/ONCOTARGET.4991
P932PMC publication ID4741978
P698PubMed publication ID26317411
P5875ResearchGate publication ID281553110

P50authorSten CornelissenQ114292659
Rainer FagerholmQ114337469
Maral JamshidiQ114337584
Valerie RheniusQ114337676
Jenny Chang-ClaudeQ21263057
Montserrat García-ClosasQ28356305
Kamila CzeneQ28484009
Angela CoxQ28484012
Barbara BurwinkelQ28484015
Hermann BrennerQ28958315
Kristiina AittomäkiQ29840622
Heli NevanlinnaQ29840669
Simon S. CrossQ30505778
Alison DunningQ30506457
Graham GilesQ30524411
John HopperQ56726496
Joe DennisQ56875626
Douglas F. EastonQ59812154
Paul D P PharoahQ61822938
Per HallQ62593354
Fergus J. CouchQ63018779
Peter A. FaschingQ64005064
Jacques SimardQ64516110
Irene L AndrulisQ64516140
Catriona A. McLeanQ68267862
Jonine FigueroaQ71778357
Sara MargolinQ72940025
Stig Egil BojesenQ72992763
Christopher A. HaimanQ73606228
Carl BlomqvistQ73625505
Veli-Matti KosmaQ37068464
Arto MannermaaQ37070123
Kyriaki MichailidouQ37070465
Katri PylkäsQ37071955
Robert WinqvistQ37074224
Peter DevileeQ37361664
Jingmei LiQ37371985
Marjanka K SchmidtQ37372106
kConFab InvestigatorsQ42807245
Melissa C. SoutheyQ55446228
Sofia KhanQ56551025
Anja RudolphQ56722646
Brian E. HendersonQ73660621
Henrik FlygerQ74012148
Maartje J. HooningQ74014444
Rob TollenaarQ77085802
Julia A. KnightQ78316584
Janet E. OlsonQ78318964
Bernd HolleczekQ81746600
Frederik MarméQ88268377
Christian R LoehbergQ91797594
Ines NevelsteenQ97522292
Manjeet K BollaQ114270702
Hatef DarabiQ114292651
P2093author name stringQin Wang
Qi Guo
John W M Martens
Laurien Van Dyck
P2860cites workAn integrated encyclopedia of DNA elements in the human genomeQ22122150
Data, information, knowledge and principle: back to metabolism in KEGGQ24568332
Is NF-kappaB a good target for cancer therapy? Hopes and pitfallsQ24570128
A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelAQ24610268
Membrane trafficking of death receptors: implications on signallingQ26852802
TNF-R1 signaling: a beautiful pathwayQ28201944
Regulation and function of IKK and IKK-related kinasesQ28268930
Proteomics-based identification of proteins interacting with Smad3: SREBP-2 forms a complex with Smad3 and inhibits its transcriptional activityQ28291746
Large-scale genotyping identifies 41 new loci associated with breast cancer riskQ29416989
Shared principles in NF-kappaB signalingQ29547234
NF-kappaB in cancer: from innocent bystander to major culpritQ29614603
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsQ29614700
Annotation of functional variation in personal genomes using RegulomeDBQ29614867
HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variantsQ29614906
SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMapQ29614907
Crosstalk in NF-κB signaling pathwaysQ29617418
NQO1 expression correlates inversely with NFκB activation in human breast cancerQ57306207
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapyQ33848895
Recurrent read-through fusion transcripts in breast cancerQ33858203
Signaling for survival and apoptosis in the immune systemQ34731231
NF-κB in immunobiology.Q35348282
Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and diseaseQ35452032
Matrix eQTL: ultra fast eQTL analysis via large matrix operationsQ35947630
The role of genetic breast cancer susceptibility variants as prognostic factorsQ36142060
Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.Q36155317
IkappaB kinase complexes: gateways to NF-kappaB activation and transcriptionQ36637874
Lymphotoxins: new targets for hepatocellular carcinomaQ36914698
A pathway switch directs BAFF signaling to distinct NFκB transcription factors in maturing and proliferating B cells.Q36957946
Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3Q73540287
Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancerQ37104237
NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity.Q37349742
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancerQ37376029
Immuno-modulatory gene polymorphisms and outcome in breast and ovarian cancerQ37610477
The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer developmentQ37770209
Non-canonical NF-κB signaling pathwayQ37822660
Role of nuclear factor-ĸB in breast and colorectal cancerQ38041500
Widespread genetic epistasis among cancer genes.Q38939422
IKK(α) controls canonical TGF(ß)-SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in panc1 cellsQ39631094
Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin.Q40077063
An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway.Q40472871
Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.Q42496035
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancerQ46567991
Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancerQ47904430
The shaping and functional consequences of the microRNA landscape in breast cancer.Q50481028
Genetic deletion of NAD(P)H:quinone oxidoreductase 1 abrogates activation of nuclear factor-kappaB, IkappaBalpha kinase, c-Jun N-terminal kinase, Akt, p38, and p44/42 mitogen-activated protein kinases and potentiates apoptosis.Q53346452
BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.Q53664665
Genetic model testing and statistical power in population-based association studies of quantitative traitsQ79920980
P433issue35
P407language of work or nameEnglishQ1860
P921main subjectNF-κBQ411114
P304page(s)37979-37994
P577publication date2015-07-22
P1433published inOncotargetQ1573155
P1476titleSNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival
P478volume6

Reverse relations

cites work (P2860)
Q90356595Association of Genetic Variants in NF-kB with Susceptibility to Breast Cancer: a Case Control Study
Q38699757Bispecific antibody suppresses osteosarcoma aggressiveness through regulation of NF-κB signaling pathway
Q41923166Bmi‑1‑targeting suppresses osteosarcoma aggressiveness through the NF‑κB signaling pathway
Q62779828Enriched power of disease-concordant twin-case-only design in detecting interactions in genome-wide association studies
Q64040390Genome-wide association study of germline variants and breast cancer-specific mortality
Q92809023Immunomodulatory Drugs Alter the Metabolism and the Extracellular Release of Soluble Mediators by Normal Monocytes
Q47103130Individual Differences in Social Behavior and Cortical Vasopressin Receptor: Genetics, Epigenetics, and Evolution
Q92424653Investigation of the variants at the binding site of inflammatory transcription factor NF-κB in patients with end-stage renal disease
Q54950358Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.
Q36329503SNP by SNP by environment interaction network of alcoholism
Q42054665SNP-SNP interactions as risk factors for aggressive prostate cancer.
Q97883645SNPs in lncRNA Regions and Breast Cancer Risk
Q50308942Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-κB signaling pathway.

Search more.